JP2000236877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000236877A5 JP2000236877A5 JP1999093232A JP9323299A JP2000236877A5 JP 2000236877 A5 JP2000236877 A5 JP 2000236877A5 JP 1999093232 A JP1999093232 A JP 1999093232A JP 9323299 A JP9323299 A JP 9323299A JP 2000236877 A5 JP2000236877 A5 JP 2000236877A5
- Authority
- JP
- Japan
- Prior art keywords
- quality control
- human
- substance
- standard substance
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 description 6
- 238000003908 quality control method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11093232A JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11093232A JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000236877A JP2000236877A (ja) | 2000-09-05 |
| JP2000236877A5 true JP2000236877A5 (https=) | 2006-03-09 |
Family
ID=14076805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11093232A Pending JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000236877A (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002052278A1 (en) * | 2000-12-22 | 2002-07-04 | International Reagents Corporation | Clinical examination precision guarantee system |
| GB0202633D0 (en) * | 2002-02-05 | 2002-03-20 | Delta Biotechnology Ltd | Stabilization of protein preparations |
| JP4436853B2 (ja) * | 2007-06-18 | 2010-03-24 | シスメックス株式会社 | 精度管理装置および精度管理方法 |
| JP4436855B2 (ja) * | 2007-07-26 | 2010-03-24 | シスメックス株式会社 | 精度管理方法 |
| JP4436856B2 (ja) * | 2007-07-26 | 2010-03-24 | シスメックス株式会社 | 精度管理方法 |
| KR101577839B1 (ko) * | 2007-08-07 | 2015-12-15 | 추가이 세이야쿠 가부시키가이샤 | 이종 단백질의 제조 방법 |
| JP4436879B2 (ja) * | 2008-10-28 | 2010-03-24 | シスメックス株式会社 | 精度管理方法 |
| US9557328B2 (en) | 2009-06-30 | 2017-01-31 | Koninklijke Philips N.V. | Magnetic sensor device, method of operating such a device and sample |
| CN113049839B (zh) * | 2019-12-27 | 2022-11-29 | 桂林英美特生物技术研究所 | 一种稳定的肝功能类复合质控品 |
-
1999
- 1999-02-23 JP JP11093232A patent/JP2000236877A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999066054A3 (en) | Erythropoietin analog-human serum albumin fusion protein | |
| WO2001055173A8 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001266787A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001262942A1 (en) | Albumin fusion proteins | |
| JP2003524368A5 (https=) | ||
| AU1593001A (en) | Recombinant gelatin in vaccines | |
| JP2000236877A5 (https=) | ||
| WO1999020760A3 (en) | Herg family potassium ion channel genes and protein | |
| WO2001055441A8 (en) | Nucleic acids, proteins, and antibodies | |
| AU2486900A (en) | Rubredoxin fusion proteins, protein expression system and methods | |
| WO2004058186A3 (en) | Formulations for pulmonary delivery | |
| ZA200202815B (en) | Viral particles with exogenous internal epitopes. | |
| AU3502997A (en) | Recombinant fusion protein comprising pdc-e2, bcoadc-e2, and ogdc-e2 and uses thereof | |
| AU6118398A (en) | Physiologically active protein originating in mammals | |
| AU7625598A (en) | Novel protein with chemokine activity | |
| AU2002250254A1 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001042297A3 (en) | Clasp-3 transmembrane protein | |
| AU2001229508A1 (en) | Nucleic acids, proteins, and antibodies | |
| WO1999063097A3 (en) | Caspase-9 deficient animals and the use thereof | |
| WO1991013984A3 (en) | Interleukin-4 binding proteins | |
| JPH1132773A5 (https=) | ||
| HK1028614A (en) | Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors | |
| AUPP004197A0 (en) | Novel hbv binding protein and portions thereof | |
| AU2001243137A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001236466A1 (en) | Nucleic acids, proteins, and antibodies |